Goldman Sachs analyst Noah Poponak lowered the firm’s price target on Booz Allen (BAH) to $80 from $93 and keeps a Sell rating on the shares. Revenue declined in the quarter at an accelerated pace, and the company revised FY26 guidance for revenue down 7%, EBITDA down 10%, and EPS down 13%, the analyst tells investors in a research note. A U.S. government funding re-prioritization is impacting Booz Allen, while Goldman also continues to see risk to margins as the customer looks to shift more risk to companies via contract terms.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAH:
- BofA Double-Downgrades Booz Allen (BAH) after Weak Q2 Results
- Booz Allen Hamilton Earnings Call: Mixed Sentiment Amid Challenges
- Booz Allen price target lowered to $106 from $119 at Stifel
- Booz Allen price target lowered to $90 from $110 at Truist
- BofA double downgrades Booz Allen to Underperform on civil weakness
